Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2008;103:493-501
Published online before print July 25, 2008, doi: 10.1161/CIRCRESAHA.108.181487
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
103/5/493    most recent
CIRCRESAHA.108.181487v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rouf, R.
Right arrow Articles by Huggins, G. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rouf, R.
Right arrow Articles by Huggins, G. S.
Related Collections
Right arrow Contractile function
Right arrow Congestive
Right arrow Animal models of human disease
Right arrow Physiological and pathological control of gene expression
(Circulation Research. 2008;103:493.)
© 2008 American Heart Association, Inc.


Molecular Medicine

Increased FOG-2 in Failing Myocardium Disrupts Thyroid Hormone–Dependent SERCA2 Gene Transcription

Rosanne Rouf, Sarah Greytak, Eric C. Wooten, Jing Wu, Jay Boltax, Michael Picard, Eric C. Svensson, Wolfgang H. Dillmann, Richard D. Patten, Gordon S. Huggins

From the MCRI Center for Translational Genomics (R.R., S.G., E.C.W., J.W., J.B., R.D.P., G.S.H.), Molecular Cardiology Research Institute, Tufts Medical Center, Boston, Mass; Cardiology Unit (M.P.), Massachusetts General Hospital, Boston, Mass; Department of Medicine (E.C.S.), University of Chicago, Ill; and Division of Endocrinology and Metabolism (W.H.D.), University of California, San Diego.

Correspondence to Gordon S. Huggins, MD, MCRI Center for Translational Genomics, Molecular Cardiology Research Institute, Tufts University School of Medicine, 750 Washington St, Box 8486, Boston, MA 02111. ghuggins{at}tuftsmedicalcenter.org

Reduced expression of sarcoplasmic reticulum calcium ATPase (SERCA)2 and other genes in the adult cardiac gene program has raised consideration of an impaired responsiveness to thyroid hormone (T3) that develops in the advanced failing heart. Here, we show that human and murine cardiomyopathy hearts have increased expression of friend of GATA (FOG)-2, a cardiac nuclear hormone receptor corepressor protein. Cardiac-specific overexpression of FOG-2 in transgenic mice led to depressed cardiac function, activation of the fetal gene program, congestive heart failure, and early death. SERCA2 transcript and protein levels were reduced in FOG-2 transgenic hearts, and FOG-2 overexpression impaired T3-mediated SERCA2 expression in cultured cardiomyocytes. FOG-2 physically interacts with thyroid hormone receptor-{alpha}1 and abrogated even high levels of T3-mediated SERCA2 promoter activity. These results demonstrate that SERCA2 is an important target of FOG-2 and that increased FOG-2 expression may contribute to a decline in cardiac function in end-stage heart failure by impaired T3 signaling.


Key Words: friend of GATA-2 • thyroid hormone receptor • sarcoplasmic reticulum calcium-activated ATPase-2 • heart failure